Inspiration meets innovation at Brandweek, the ultimate marketing experience. Join industry luminaries, rising talent and strategic experts in Phoenix, Arizona this September 23–26 to assess challenges, develop solutions and create new pathways for growth. Register early to save.
The $150 million media-only review for Glaxo-Wellcome’s business is down to three contenders, including buying incumbent The Media Edge, New York, sources confirmed last week.
The other two agencies in the running for planning and buying duties are Optimum Media, New York, and the Atlanta office of Western Initiative Media Worldwide.
Not making the cut are planning incumbent Wilson Media Group, New York, and creative shop Grey Advertising, also New York (pitching via MediaCom). Blueprint Communications in Atlanta is handling the review.
Glaxo will start visiting agencies this week; a decision is expected before the end of the month.
The client began its review last year [Adweek, Dec.
WORK SMARTER - LEARN, GROW AND BE INSPIRED.
Subscribe today!
To Read the Full Story Become an Adweek+ Subscriber
Already a member? Sign in